Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
McLeod D . Central retinal artery occlusion and cerebral stroke. Eye 2013; 27: 1422.
Varma DD, Cugati S, Lee AW, Chen CS . A review of central retinal artery occlusion: clinical presentation and management. Eye 2013; 27: 688–697.
Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E et al. Definition and Evaluation of Transient Ischemic Attack: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease: the American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009; 40: 2276–2293.
Astrup J, Symon L, Branston NM, Lassen NA . Cortical evoked potential and extracellular K+ and H+ levels at critical levels of brain ischemia. Stroke 1977; 8: 51–57.
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D et al. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke. N Engl J Med 2008; 359: 1317–1329.
Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352–2363.
Feltgen N, Neubauer A, Jurklies B, Schmoor C, Schmidt D, Wanke J et al. Mutlicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusio: design issues and implications. EAGLE study report no. 1. Graefes Arch Clin Exp Ophthalmol 2006; 244: 950–956.
Chen CS, Lee AW, Campbell B, Lee T, Paine M, Fraser C et al. Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke 2011; 42: 2229–2234.
Hayreh SS, Zimmerman MB, Kimura A, Sanon A . Central retinal artery occlusion. Retinal survival time. Exp Eye Res 2004; 78: 723–736.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Lee, A., Chen, C., Cugati, S. et al. Reply: ‘Central retinal artery occlusion and cerebral stroke’. Eye 27, 1422–1423 (2013). https://doi.org/10.1038/eye.2013.216
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2013.216
